The pooled results showed that the risk of CAD (OR = 5.99, 95% CI: 1.13–31.77, p = 0.04) and overall CVDs (OR = 1.68, 95% CI: 1.14–2.48, p = 0.009) increased with FGF21. This evidence concerns the gene FGF21 and coronary artery disorder.